Moderna reported a significant beat in its first-quarter 2026 financials, fueled by a surge in international vaccine demand. The company's revenue grew by approximately 260% year-over-year.
- Revenue of $389 million reported for Q1 2026
- Year-over-year revenue growth of approximately 260%